Moreover, we further confirmed that PGC1α is central to the disease improvements seen with NR supplementation during experimental colitis, as NR supplementation did not improve DAI scores in PGC1αΔIEC mice subjected to DSS. The gene discussed is PPARGC1A; the disease is colitis.